Security key
M96088105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 13,022,042
- Total 13F value
- $115,449,037
- Share change
- -274,556
- Put/Call ratio
- 0.29%
- SEC-reported price per share
- $8.87
- Number of holders
- 63
- Value change
- -$2,381,858
- Number of buys
- 22
- Number of sells
- 20
- Shares outstanding
- 48,549,968
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
63
Top holders
10
URGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
UroGen Pharma Ltd. SEC filings
UroGen Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M96088105
Recent filing periods:
Ownership snapshot
Top reported holders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ran Nussbaum
Disclosed value leader
Ran Nussbaum
Comparable rows
0/15
Latest evidence
21 Oct 2022
3/4/5
13F
Highest disclosed value: $26,747,876
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Ran Nussbaum has the largest disclosed position value at $26.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ran Nussbaum's linked filing trail.
Disclosed position value
Top 5
Ran Nussbaum
$26.75M
MENORA MIVTACHIM HOLDINGS LTD.
$24.29M
Stonepine Capital Management, LLC
$9.35M
CREDIT SUISSE AG/
$8.82M
Harel Insurance Investments & Fin...
$8.53M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ran Nussbaum |
3/4/5
Director
|
—
denominator unverified
|
$26,747,876
1,485,168 shares
|
— | 21 Oct 2022 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
—
denominator unverified
|
$24,286,000
2,919,003 shares
|
— | 30 Sep 2022 |
| Stonepine Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$9,354,000
1,124,220 shares
|
— | 30 Sep 2022 |
| CREDIT SUISSE AG/ |
13F
Company
|
—
denominator unverified
|
$8,819,000
1,060,000 shares
|
— | 30 Sep 2022 |
| Harel Insurance Investments & Financial Services Ltd. |
13F
Company
|
—
denominator unverified
|
$8,533,000
1,025,583 shares
|
— | 30 Sep 2022 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
—
denominator unverified
|
$7,267,000
873,424 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
63
Shares
13,022,042
Rows available
63
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
56
Q4 2022 holders
63
Holder diff
7
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend